🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RIFAstrat is a Phase 3, double-blind, placebo-controlled, non-inferiority t...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07118696
Treatments Being Tested
Tuberculosis (TB) is caused by mycobacterial organism. It is the leading in...
Status
Recruiting
Location
National Tuberculosis Reference Laboratory
Start Date
2024-01-03
Trial ID
NCT06199921
BEAT Tuberculosis is a phase 3, open label, multi-centre, randomized contro...
Status
Completed
Location
Jose Pearson TB Hospital
Start Date
2019-08-22
Trial ID
NCT04062201
The purpose of this study is to assess pharmacokinetic parameters of atorva...
Status
Recruiting
Location
National Tuberculosis and Leprosy Training Centre, Saye
Start Date
2026-01-03
Trial ID
NCT07303699
The current standard management strategy for drug-sensitive pulmonary tuber...
Status
Completed
Location
National Institute of TB and Respiratory Diseases
Start Date
2018-03-21
Trial ID
NCT03474198
DATURA trial is a phase III, multicenter, two-arm, open-label, randomized s...
Status
Completed
Location
National Center for HIV/AIDS, Dermatology and STD (NCHADS)
Start Date
2022-04-21
Trial ID
NCT04738812
Treatments Being Tested
The UNITE4TB consortium is a group of universities and pharmaceutical compa...
Status
Recruiting
Location
PMSI Institute of Pneumology "Chiril Draganiuc"
Start Date
2024-01-09
Trial ID
NCT06114628
Tuberculosis is the current leading cause of death due to an identifiable i...
Status
Completed
Location
Eighty-fifth Hospital of PLA
Start Date
2017-12-01
Trial ID
NCT03561753
DARE-TB has been designed to address critical evidence gaps on the diagnost...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-01
Trial ID
NCT07420881
While drug-susceptible tuberculosis (TB) disease in children currently requ...
Status
Recruiting
Location
Indian Council of Medical Research - National Institute for Research in Tuberculosis
Start Date
2025-01-15
Trial ID
NCT06253715
Treatments Being Tested